{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:01:44Z","timestamp":1789012904819,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"crossref","award":["MOST107-2314-B-075B-009"],"award-info":[{"award-number":["MOST107-2314-B-075B-009"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"crossref","award":["MOST-108-2314-B-075B-001-MY3"],"award-info":[{"award-number":["MOST-108-2314-B-075B-001-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","award":["VGHKS-104-44"],"award-info":[{"award-number":["VGHKS-104-44"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","award":["VGHKS-105-57"],"award-info":[{"award-number":["VGHKS-105-57"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","award":["VGHKS-109-124"],"award-info":[{"award-number":["VGHKS-109-124"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Keloid is a skin disease characterized by exaggerated scar formation, excessive fibroblast proliferation, and excessive collagen deposition. Cancers commonly arise from a fibrotic microenvironment; e.g., hepatoma arises from liver cirrhosis, and oral cancers arise from submucosal fibrosis. As keloids are a prototypic fibroproliferative disease, this study investigated whether patients with keloids have an increased cancer risk. In a matched, population-based study, first 17,401 patients treated for keloids during 1998\u20132010 with 69,604 controls without keloids at a ratio of 1:4 were evaluated. The association between keloids and risk of cancer was estimated by logistic regression or Cox proportional hazard regression models after adjustment of covariates. In total, 893 first-time cases of cancer were identified in the 17,401 patients with keloids. The overall cancer risk was 1.49-fold higher in the keloids group compared to controls. Regarding specific cancers, the keloids group, had a significantly higher risk of skin cancer compared to controls (Relative risk\u2009=\u20091.73). The relative risk for skin cancer was even higher for males with keloids (Relative risk\u2009=\u20092.16). Further stratified analyses also revealed a significantly higher risk of developing pancreatic cancer in female patients with keloids compared to controls (Relative risk\u2009=\u20092.19) after adjustment for known pancreatic cancer risk factors. This study indicates that patients with keloids have a higher than normal risk for several cancer types, especially skin cancers (both genders) and pancreatic cancer (females). Therefore, patients with keloids should undergo regular skin examinations, and females with keloids should regularly undergo abdominal ultrasonography.<\/jats:p>","DOI":"10.1038\/s41598-021-88789-1","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T10:04:45Z","timestamp":1619777085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Risk of cancer development in patients with keloids"],"prefix":"10.1038","volume":"11","author":[{"given":"Ying-Yi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Pin","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Hsin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hui","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ju","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee-Lung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"88789_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0190-9622(81)70048-3","volume":"4","author":"JC Murray","year":"1981","unstructured":"Murray, J. C., Pollack, S. V. & Pinnell, S. R. Keloids: A review. J. Am. Acad. Dermatol. 4, 461\u2013470 (1981).","journal-title":"J. Am. Acad. Dermatol."},{"key":"88789_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/CCID.S35252","volume":"6","author":"GG Gauglitz","year":"2013","unstructured":"Gauglitz, G. G. Management of keloids and hypertrophic scars: Current and emerging options. Clin. Cosmet. Investig. Dermatol. 6, 103\u2013114 (2013).","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"88789_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.5999\/aps.2012.39.3.184","volume":"39","author":"AS Halim","year":"2012","unstructured":"Halim, A. S., Emami, A., Salahshourifar, I. & Kannan, T. P. Keloid scarring: Understanding the genetic basis, advances, and prospects. Arch. Plast. Surg 39, 184\u2013189 (2012).","journal-title":"Arch. Plast. Surg"},{"key":"88789_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2119\/molmed.2009.00153","volume":"17","author":"GG Gauglitz","year":"2011","unstructured":"Gauglitz, G. G., Korting, H. C., Pavicic, T., Ruzicka, T. & Jeschke, M. G. Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies. Mol. Med. 17, 113\u2013125 (2011).","journal-title":"Mol. Med."},{"key":"88789_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.prs.0000195073.73580.46","volume":"117","author":"A Al-Attar","year":"2006","unstructured":"Al-Attar, A., Mess, S., Thomassen, J. M., Kauffman, C. L. & Davison, S. P. Keloid pathogenesis and treatment. Plast. Reconstr. Surg. 117, 286\u2013300 (2006).","journal-title":"Plast. Reconstr. Surg."},{"key":"88789_CR6","first-page":"468","volume":"10","author":"MH Viera","year":"2011","unstructured":"Viera, M. H., Caperton, C. V. & Berman, B. Advances in the treatment of keloids. J. Drugs Dermatol. 10, 468\u2013480 (2011).","journal-title":"J. Drugs Dermatol."},{"key":"88789_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2340\/00015555-1089","volume":"91","author":"Y He","year":"2011","unstructured":"He, Y., Merin, M. R., Sharon, V. R. & Maverakis, E. Eruptive keloids associated with breast cancer: A paraneoplastic phenomenon?. Acta Derm. Venereol. 91, 480\u2013481 (2011).","journal-title":"Acta Derm. Venereol."},{"key":"88789_CR8","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/1346-8138.13910","volume":"44","author":"M Sakaguchi","year":"2017","unstructured":"Sakaguchi, M. et al. Bilateral breast keloids in an elderly woman associated with bilateral breast cancers and high concentration of serum tumor growth factor-beta. J. Dermatol. 44, 1303\u20131308 (2017).","journal-title":"J. Dermatol."},{"key":"88789_CR9","first-page":"243","volume":"64","author":"LM Coppa","year":"1999","unstructured":"Coppa, L. M., Alam, M., Longley, B. J. & Stiller, M. J. Eruptive paraneoplastic keloids. Cutis 64, 243\u2013244 (1999).","journal-title":"Cutis"},{"key":"88789_CR10","doi-asserted-by":"publisher","first-page":"12118","DOI":"10.3748\/wjg.v20.i34.12118","volume":"20","author":"M Del Chiaro","year":"2014","unstructured":"Del Chiaro, M., Segersvard, R., Lohr, M. & Verbeke, C. Early detection and prevention of pancreatic cancer: Is it really possible today?. World J. Gastroenterol. 20, 12118\u201312131 (2014).","journal-title":"World J. Gastroenterol."},{"key":"88789_CR11","doi-asserted-by":"publisher","first-page":"11182","DOI":"10.3748\/wjg.v20.i32.11182","volume":"20","author":"AE Becker","year":"2014","unstructured":"Becker, A. E., Hernandez, Y. G., Frucht, H. & Lucas, A. L. Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection. World J. Gastroenterol. 20, 11182\u201311198 (2014).","journal-title":"World J. Gastroenterol."},{"key":"88789_CR12","doi-asserted-by":"crossref","unstructured":"Ogawa, R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int. J. Mol. Sci. 18, 606 (2017).","DOI":"10.3390\/ijms18030606"},{"key":"88789_CR13","doi-asserted-by":"publisher","first-page":"e1448327","DOI":"10.1080\/19381980.2018.1448327","volume":"9","author":"C Shi","year":"2017","unstructured":"Shi, C., Zhu, J. & Yang, D. The pivotal role of inflammation in scar\/keloid formation after acne. Dermatoendocrinology 9, e1448327 (2017).","journal-title":"Dermatoendocrinology"},{"key":"88789_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0022-4804(03)00188-4","volume":"113","author":"W Chen","year":"2003","unstructured":"Chen, W. et al. Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray. J. Surg. Res. 113, 208\u2013216 (2003).","journal-title":"J. Surg. Res."},{"key":"88789_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3892\/br.2013.169","volume":"1","author":"X Dong","year":"2013","unstructured":"Dong, X., Mao, S. & Wen, H. Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation (Review). Biomed. Rep. 1, 833\u2013836 (2013).","journal-title":"Biomed. Rep."},{"key":"88789_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1189\/jlb.1204698","volume":"78","author":"AA Maung","year":"2005","unstructured":"Maung, A. A. et al. Enhanced TLR4 reactivity following injury is mediated by increased p38 activation. J. Leukoc. Biol. 78, 565\u2013573 (2005).","journal-title":"J. Leukoc. Biol."},{"key":"88789_CR17","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.4049\/jimmunol.174.5.2957","volume":"174","author":"TJ Murphy","year":"2005","unstructured":"Murphy, T. J., Ni Choileain, N., Zang, Y., Mannick, J. A. & Lederer, J. A. CD4+CD25+ regulatory T cells control innate immune reactivity after injury. J. Immunol. 174, 2957\u20132963 (2005).","journal-title":"J. Immunol."},{"key":"88789_CR18","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.burns.2017.09.010","volume":"44","author":"PD Drummond","year":"2018","unstructured":"Drummond, P. D., Dawson, L. F., Wood, F. M. & Fear, M. W. Up-regulation of alpha1-adrenoceptors in burn and keloid scars. Burns 44, 582\u2013588 (2018).","journal-title":"Burns"},{"key":"88789_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/978-3-0348-0837-8_17","volume":"816","author":"GB Maru","year":"2014","unstructured":"Maru, G. B., Gandhi, K., Ramchandani, A. & Kumar, G. The role of inflammation in skin cancer. Adv. Exp. Med. Biol. 816, 437\u2013469 (2014).","journal-title":"Adv. Exp. Med. Biol."},{"key":"88789_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/PPO.0000000000000045","volume":"20","author":"CP Zambirinis","year":"2014","unstructured":"Zambirinis, C. P., Pushalkar, S., Saxena, D. & Miller, G. Pancreatic cancer, inflammation, and microbiome. Cancer J. 20, 195\u2013202 (2014).","journal-title":"Cancer J."},{"key":"88789_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-3-0348-0837-8_6","volume":"816","author":"S Hausmann","year":"2014","unstructured":"Hausmann, S., Kong, B., Michalski, C., Erkan, M. & Friess, H. The role of inflammation in pancreatic cancer. Adv. Exp. Med. Biol. 816, 129\u2013151 (2014).","journal-title":"Adv. Exp. Med. Biol."},{"key":"88789_CR22","first-page":"179","volume":"43","author":"TY Lee","year":"1999","unstructured":"Lee, T. Y. et al. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann. Plast. Surg. 43, 179\u2013184 (1999).","journal-title":"Ann. Plast. Surg."},{"key":"88789_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/BJ20100427","volume":"430","author":"T Liu","year":"2010","unstructured":"Liu, T. & Feng, X. H. Regulation of TGF-beta signalling by protein phosphatases. Biochem. J. 430, 191\u2013198 (2010).","journal-title":"Biochem. J."},{"key":"88789_CR24","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1365-2133.2012.11023.x","volume":"167","author":"CS Wu","year":"2012","unstructured":"Wu, C. S., Wu, P. H., Fang, A. H. & Lan, C. C. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-beta1 on collagen expression and TGF-beta\/Smad signalling in keloid fibroblasts: Implication for new therapeutic approach. Br. J. Dermatol. 167, 532\u2013541 (2012).","journal-title":"Br. J. Dermatol."},{"key":"88789_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.burns.2012.07.019","volume":"39","author":"J Chen","year":"2013","unstructured":"Chen, J., Zeng, B., Yao, H. & Xu, J. The effect of TLR4\/7 on the TGF-beta-induced Smad signal transduction pathway in human keloid. Burns 39, 465\u2013472 (2013).","journal-title":"Burns"},{"key":"88789_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.yexmp.2014.11.002","volume":"97","author":"Z Chen","year":"2014","unstructured":"Chen, Z. et al. Ski diminishes TGF-beta1-induced myofibroblast phenotype via up-regulating Meox2 expression. Exp. Mol. Pathol. 97, 542\u2013549 (2014).","journal-title":"Exp. Mol. Pathol."},{"key":"88789_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/107999000312540","volume":"20","author":"EE Tredget","year":"2000","unstructured":"Tredget, E. E., Wang, R., Shen, Q., Scott, P. G. & Ghahary, A. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: Antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J. Interferon. Cytokine Res. 20, 143\u2013151 (2000).","journal-title":"J. Interferon. Cytokine Res."},{"key":"88789_CR28","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1006\/cyto.1995.1025","volume":"7","author":"A Ghahary","year":"1995","unstructured":"Ghahary, A., Shen, Y. J., Scott, P. G. & Tredget, E. E. Immunolocalization of TGF-beta 1 in human hypertrophic scar and normal dermal tissues. Cytokine 7, 184\u2013190 (1995).","journal-title":"Cytokine"},{"key":"88789_CR29","doi-asserted-by":"publisher","first-page":"32231","DOI":"10.1038\/srep32231","volume":"6","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. TGF-beta1 promotes scar fibroblasts proliferation and transdifferentiation via up-regulating MicroRNA-21. Sci. Rep. 6, 32231 (2016).","journal-title":"Sci. Rep."},{"key":"88789_CR30","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1097\/01.TA.0000114087.46566.EB","volume":"57","author":"TT Phan","year":"2004","unstructured":"Phan, T. T. et al. Suppression of transforming growth factor beta\/smad signaling in keloid-derived fibroblasts by quercetin: Implications for the treatment of excessive scars. J. Trauma 57, 1032\u20131037 (2004).","journal-title":"J. Trauma"},{"key":"88789_CR31","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1365-2133.2009.09511.x","volume":"162","author":"S He","year":"2010","unstructured":"He, S. et al. Mechanisms of transforming growth factor beta(1)\/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts. Br. J. Dermatol. 162, 538\u2013546 (2010).","journal-title":"Br. J. Dermatol."},{"key":"88789_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.7150\/ijbs.23230","volume":"14","author":"M Zhao","year":"2018","unstructured":"Zhao, M., Mishra, L. & Deng, C. X. The role of TGF-beta\/SMAD4 signaling in cancer. Int. J. Biol. Sci. 14, 111\u2013123 (2018).","journal-title":"Int. J. Biol. Sci."},{"key":"88789_CR33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gut.44.4.534","volume":"44","author":"MV Apte","year":"1999","unstructured":"Apte, M. V. et al. Pancreatic stellate cells are activated by proinflammatory cytokines: Implications for pancreatic fibrogenesis. Gut 44, 534\u2013541 (1999).","journal-title":"Gut"},{"key":"88789_CR34","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1053\/j.gastro.2004.12.036","volume":"128","author":"MG Bachem","year":"2005","unstructured":"Bachem, M. G. et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 128, 907\u2013921 (2005).","journal-title":"Gastroenterology"},{"key":"88789_CR35","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0092-8674(01)00616-X","volume":"107","author":"V Ambros","year":"2001","unstructured":"Ambros, V. microRNAs: Tiny regulators with great potential. Cell 107, 823\u2013826 (2001).","journal-title":"Cell"},{"key":"88789_CR36","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/nar\/gki200","volume":"33","author":"AM Cheng","year":"2005","unstructured":"Cheng, A. M., Byrom, M. W., Shelton, J. & Ford, L. P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33, 1290\u20131297 (2005).","journal-title":"Nucleic Acids Res."},{"key":"88789_CR37","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.cell.2012.02.005","volume":"148","author":"JT Mendell","year":"2012","unstructured":"Mendell, J. T. & Olson, E. N. MicroRNAs in stress signaling and human disease. Cell 148, 1172\u20131187 (2012).","journal-title":"Cell"},{"key":"88789_CR38","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","volume":"137","author":"J Kota","year":"2009","unstructured":"Kota, J. et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137, 1005\u20131017 (2009).","journal-title":"Cell"},{"key":"88789_CR39","doi-asserted-by":"publisher","first-page":"759","DOI":"10.4161\/cc.7.6.5834","volume":"7","author":"A Esquela-Kerscher","year":"2008","unstructured":"Esquela-Kerscher, A. et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7, 759\u2013764 (2008).","journal-title":"Cell Cycle"},{"key":"88789_CR40","doi-asserted-by":"publisher","first-page":"121118","DOI":"10.1126\/scitranslmed.3003205","volume":"4","author":"BN Chau","year":"2012","unstructured":"Chau, B. N. et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci. Transl. Med. 4, 121118 (2012).","journal-title":"Sci. Transl. Med."},{"key":"88789_CR41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.clinbiochem.2013.01.008","volume":"46","author":"D Voller","year":"2013","unstructured":"Voller, D., Ott, C. & Bosserhoff, A. MicroRNAs in malignant melanoma. Clin. Biochem. 46, 909\u2013917 (2013).","journal-title":"Clin. Biochem."},{"key":"88789_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00266-011-9773-1","volume":"36","author":"Y Liu","year":"2012","unstructured":"Liu, Y., Yang, D., Xiao, Z. & Zhang, M. miRNA expression profiles in keloid tissue and corresponding normal skin tissue. Aesthetic. Plast. Surg. 36, 193\u2013201 (2012).","journal-title":"Aesthetic. Plast. Surg."},{"key":"88789_CR43","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/jid.2012.22","volume":"132","author":"K Kashiyama","year":"2012","unstructured":"Kashiyama, K. et al. miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts. J. Invest. Dermatol. 132, 1597\u20131604 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"88789_CR44","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/abbs\/gmt057","volume":"45","author":"C Li","year":"2013","unstructured":"Li, C. et al. Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs. Acta Biochim. Biophys. Sin (Shanghai) 45, 692\u2013699 (2013).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"88789_CR45","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/cpr.12225","volume":"48","author":"X Yu","year":"2015","unstructured":"Yu, X., Li, Z., Chan, M. T. & Wu, W. K. microRNA deregulation in keloids: An opportunity for clinical intervention?. Cell Prolif. 48, 626\u2013630 (2015).","journal-title":"Cell Prolif."},{"key":"88789_CR46","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.4238\/2014.April.14.2","volume":"13","author":"ZY Wu","year":"2014","unstructured":"Wu, Z. Y. et al. Keloid microRNA expression analysis and the influence of miR-199a-5p on the proliferation of keloid fibroblasts. Genet. Mol. Res. 13, 2727\u20132738 (2014).","journal-title":"Genet. Mol. Res."},{"key":"88789_CR47","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1158\/1078-0432.CCR-11-0679","volume":"18","author":"NB Jamieson","year":"2012","unstructured":"Jamieson, N. B. et al. MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin. Cancer Res. 18, 534\u2013545 (2012).","journal-title":"Clin. Cancer Res."},{"key":"88789_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ncb2672","volume":"15","author":"J Chou","year":"2013","unstructured":"Chou, J. et al. GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat. Cell Biol. 15, 201\u2013213 (2013).","journal-title":"Nat. Cell Biol."},{"key":"88789_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1478-811X-10-41","volume":"10","author":"MJ Schmitt","year":"2012","unstructured":"Schmitt, M. J. et al. Interferon-gamma-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. Cell Commun. Signal 10, 41 (2012).","journal-title":"Cell Commun. Signal"},{"key":"88789_CR50","doi-asserted-by":"crossref","unstructured":"Kwon, J. J. et al. Pathophysiological role of microRNA-29 in pancreatic cancer stroma. Sci. Rep. 5, 11450 (2015).","DOI":"10.1038\/srep11450"},{"key":"88789_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2017. CA Cancer J. Clin. 67, 7\u201330 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"88789_CR52","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jpedsurg.2012.03.026","volume":"47","author":"AL Speer","year":"2012","unstructured":"Speer, A. L., Barthel, E. R., Patel, M. M. & Grikscheit, T. C. Solid pseudopapillary tumor of the pancreas: A single-institution 20-year series of pediatric patients. J. Pediatr. Surg. 47, 1217\u20131222 (2012).","journal-title":"J. Pediatr. Surg."},{"key":"88789_CR53","first-page":"S59","volume":"4","author":"C Pasquali","year":"2005","unstructured":"Pasquali, C., Sperti, C., Baratella, P., Liessi, G. & Pedrazzoli, S. Enucleation-resection of pancreatic neuroendocrine tumors: 25 years of experience. Suppl. Tumori. 4, S59-60 (2005).","journal-title":"Suppl. Tumori."},{"key":"88789_CR54","first-page":"639","volume":"40","author":"S Hafsi","year":"2012","unstructured":"Hafsi, S. et al. Gene alterations in the PI3K\/PTEN\/AKT pathway as a mechanism of drug-resistance (review). Int. J. Oncol. 40, 639\u2013644 (2012).","journal-title":"Int. J. Oncol."},{"key":"88789_CR55","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1593\/neo.05355","volume":"7","author":"Y Shi","year":"2005","unstructured":"Shi, Y. et al. Optimal classes of chemotherapeutic agents sensitized by specific small-molecule inhibitors of akt in vitro and in vivo. Neoplasia 7, 992\u20131000 (2005).","journal-title":"Neoplasia"},{"key":"88789_CR56","doi-asserted-by":"publisher","first-page":"16759","DOI":"10.1038\/srep16759","volume":"5","author":"S Morvaridi","year":"2015","unstructured":"Morvaridi, S., Dhall, D., Greene, M. I., Pandol, S. J. & Wang, Q. Role of YAP and TAZ in pancreatic ductal adenocarcinoma and in stellate cells associated with cancer and chronic pancreatitis. Sci. Rep. 5, 16759 (2015).","journal-title":"Sci. Rep."},{"key":"88789_CR57","doi-asserted-by":"publisher","first-page":"e0171667","DOI":"10.1371\/journal.pone.0171667","volume":"12","author":"CY Wu","year":"2017","unstructured":"Wu, C. Y. et al. Osteoporosis in adult patients with atopic dermatitis: A nationwide population-based study. PLoS ONE 12, e0171667 (2017).","journal-title":"PLoS ONE"},{"key":"88789_CR58","doi-asserted-by":"publisher","first-page":"e022865","DOI":"10.1136\/bmjopen-2018-022865","volume":"8","author":"YY Lu","year":"2018","unstructured":"Lu, Y. Y. et al. Keloid risk in patients with atopic dermatitis: A nationwide retrospective cohort study in Taiwan. BMJ Open 8, e022865 (2018).","journal-title":"BMJ Open"},{"key":"88789_CR59","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00403-014-1491-5","volume":"306","author":"LM Sun","year":"2014","unstructured":"Sun, L. M., Wang, K. H. & Lee, Y. C. Keloid incidence in Asian people and its comorbidity with other fibrosis-related diseases: A nationwide population-based study. Arch Dermatol. Res. 306, 803\u2013808 (2014).","journal-title":"Arch Dermatol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88789-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88789-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T07:32:54Z","timestamp":1670052774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88789-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88789"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88789-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"assertion":[{"value":"25 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9390"}}